Upgrade to SI Premium - Free Trial

Veru reports second quarter fiscal 2026 results and obesity trial update

May 13, 2026 6:30 AM
Veru Inc. (NASDAQ: VERU) reported financial results for its fiscal 2026 second quarter ended March 31, 2026, showing reduced losses ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA